Connexin-43 can delay early recurrence and metastasis in patients with hepatitis B-related hepatocellular carcinoma and low serum alpha-fetoprotein after radical hepatectomy

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Wang, Zu Sen ^a   Wu, Li Qun ^a   Yi, Xin ^a   Geng, Chao ^a   Li, Yu Jun ^a   Yao, Ru Yong ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Alpha fetoprotein; Carcinoma; CD105; Cx43; Early recurrence; Hepatitis B; Hepatocellular; Metastasis; Prognosis; VEGF

Indexed keywords

ALPHA FETOPROTEIN; CONNEXIN 43; ENDOGLIN; MESSENGER RNA; VASCULOTROPIN; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; GJA1 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; TUMOR MARKER; VASCULOTROPIN A;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; TUMOR EMBOLISM; BIOSYNTHESIS; COMPLICATION; KAPLAN MEIER METHOD; LIVER TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TUMOR RECURRENCE; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; ANTIGENS, CD; CARCINOMA, HEPATOCELLULAR; CONNEXIN 43; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HEPATITIS B, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84879245892     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-306     Document Type: Article

References (26)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127(12):2893-2917. 10.1002/ijc.25516, 21351269.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90. 10.3322/caac.20107, 21296855.
3. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42(5):1208-1236. 10.1002/hep.20933, 16250051.
4. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996, 334(11):693-699. 10.1056/NEJM199603143341104, 8594428.
5. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003, 362(9399):1907-1917. 10.1016/S0140-6736(03)14964-1, 14667750.
6. Tung-Ping PR, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000, 232(1):10-24. 10.1097/00000658-200007000-00003, 1421103, 10862190.
7. Poon RT, Fan ST, Lo CM, Liu CL, Ng IO, Wong J. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol 2000, 18(5):1094-1101.
8. Toyama T, Hiramatsu N, Yakushijin T, et al. A new prognostic system for hepatocellular carcinoma including recurrent cases: a study of 861 patients in a single institution. J Clin Gastroenterol 2008, 42(3):317-322.
9. Ariizumi S, Takasaki K, Yamamoto M, Ohtsubo T, Saito A, Nakano M. Multicentric hepatocellular carcinomas tend to grow in more damaged segments of the liver. J Gastroenterol 2000, 35(6):441-444. 10.1007/s005350070089, 10864351.
10. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006, 45(4):529-538. 10.1016/j.jhep.2006.05.013, 16879891.
11. Han YF, Zhao J, Ma LY, et al. Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma. World J Gastroenterol 2011, 17(38):4258-4270. 10.3748/wjg.v17.i38.4258, 3214700, 22090781.
12. Kojima T, Yamamoto M, Mochizuki C, Mitaka T, Sawada N, Mochizuki Y. Different changes in expression and function of connexin 26 and connexin 32 during DNA synthesis and redifferentiation in primary rat hepatocytes using a DMSO culture system. Hepatology 1997, 26(3):585-597. 10.1002/hep.510260309, 9303487.
13. Ara C, Massimi M, Devirgiliis CL. Retinoic acid modulates gap junctional intercellular communication in hepatocytes and hepatoma cells. Cell Mol Life Sci 2002, 59(10):1758-1765. 10.1007/PL00012503, 12475186.
14. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991, 324(1):1-8. 10.1056/NEJM199101033240101, 1701519.
15. Tang ZY, Ye SL, Liu YK, et al. A decade's studies on metastasis of hepatocellular carcinoma. J Cancer Res Clin Oncol 2004, 130(4):187-196. 10.1007/s00432-003-0511-1, 14685850.
16. Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 2000, 89(3):500-507. 10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.0.CO;2-O, 10931448.
17. Mesnil M, Crespin S, Avanzo JL, Zaidan-Dagli ML. Defective gap junctional intercellular communication in the carcinogenic process. Biochim Biophys Acta 2005, 1719(1-2):125-145.
18. Loewenstein WR, Kanno Y. Intercellular communication and tissue growth. I. Cancerous growth. J Cell Biol 1967, 33(2):225-234. 10.1083/jcb.33.2.225, 2108359, 6039367.
19. Loewenstein WR, Kanno Y. Intercellular communication and the control of tissue growth: lack of communication between cancer cells. Nature 1966, 209(5029):1248-1249. 10.1038/2091248a0, 5956321.
20. Trosko JE. The role of stem cells and gap junctional intercellular communication in carcinogenesis. J Biochem Mol Biol 2003, 36(1):43-48. 10.5483/BMBRep.2003.36.1.043, 12542974.
21. Tangkijvanich P, Anukulkarnkusol N, Suwangool P, et al. Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels. J Clin Gastroenterol 2000, 31(4):302-308. 10.1097/00004836-200012000-00007, 11129271.
22. Ma XD, Sui YF, Wang WL. Expression of gap junction genes connexin 32, connexin 43 and their proteins in hepatocellular carcinoma and normal liver tissues. World J Gastroenterol 2000, 6(1):66-69.
23. Ionta M, Ferreira RA, Pfister SC, Machado-Santelli GM. Exogenous Cx43 expression decrease cell proliferation rate in rat hepatocarcinoma cells independently of functional gap junction. Cancer Cell Int 2009, 9:22. 10.1186/1475-2867-9-22, 2738655, 19678939.
24. Ogawa K, Pitchakarn P, Suzuki S, et al. Silencing of connexin 43 suppresses invasion, migration and lung metastasis of rat hepatocellular carcinoma cells. Cancer Sci 2012, 103(5):860-867. 10.1111/j.1349-7006.2012.02228.x, 22320152.
25. Yang LY, Lu WQ, Huang GW, Wang W. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma. BMC Cancer 2006, 6:110. 10.1186/1471-2407-6-110, 1475877, 16650286.
26. Poon RT, Ng IO, Lau C, et al. Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann Surg 2001, 233(2):227-235. 10.1097/00000658-200102000-00012, 1421205, 11176129.